Moors & Cabot’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Sell |
4,134
-1,363
| -25% | -$607K | 0.09% | 218 |
|
|
2025
Q1 | $2.67M | Buy |
5,497
+1,894
| +53% | +$918K | 0.14% | 147 |
|
|
2024
Q4 | $1.45M | Buy |
3,603
+25
| +0.7% | +$10.1K | 0.07% | 250 |
|
|
2024
Q3 | $1.66M | Sell |
3,578
-161
| -4% | -$74.9K | 0.08% | 219 |
|
|
2024
Q2 | $1.75M | Sell |
3,739
-201
| -5% | -$94.2K | 0.09% | 192 |
|
|
2024
Q1 | $1.65M | Buy |
3,940
+47
| +1% | +$19.6K | 0.09% | 214 |
|
|
2023
Q4 | $1.58M | Sell |
3,893
-422
| -10% | -$172K | 0.1% | 196 |
|
|
2023
Q3 | $1.5M | Sell |
4,315
-189
| -4% | -$65.7K | 0.1% | 195 |
|
|
2023
Q2 | $1.59M | Buy |
4,504
+412
| +10% | +$145K | 0.11% | 192 |
|
|
2023
Q1 | $1.29M | Sell |
4,092
-194
| -5% | -$61.1K | 0.09% | 229 |
|
|
2022
Q4 | $1.24M | Buy |
4,286
+198
| +5% | +$57.2K | 0.09% | 234 |
|
|
2022
Q3 | $1.18M | Buy |
4,088
+23
| +0.6% | +$6.66K | 0.09% | 230 |
|
|
2022
Q2 | $1.15M | Buy |
4,065
+182
| +5% | +$51.3K | 0.08% | 238 |
|
|
2022
Q1 | $1.01M | Buy |
3,883
+701
| +22% | +$183K | 0.06% | 289 |
|
|
2021
Q4 | $699K | Buy |
+3,182
| New | +$699K | 0.04% | 375 |
|
|
2021
Q1 | – | Sell |
-1,642
| Closed | -$387K | – | 797 |
|
|
2020
Q4 | $387K | Sell |
1,642
-164
| -9% | -$38.7K | 0.03% | 449 |
|
|
2020
Q3 | $491K | Sell |
1,806
-219
| -11% | -$59.5K | 0.05% | 332 |
|
|
2020
Q2 | $591K | Buy |
2,025
+47
| +2% | +$13.7K | 0.06% | 278 |
|
|
2020
Q1 | $474K | Sell |
1,978
-286
| -13% | -$68.5K | 0.07% | 258 |
|
|
2019
Q4 | $496K | Buy |
+2,264
| New | +$496K | 0.05% | 345 |
|